Researchers dig into 12,000 patient records to compare depression therapies
NCT ID NCT06997549
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks back at the treatment records of about 12,000 people with depression, OCD, or anxiety. Researchers will compare how well two treatments—NeuroStar TMS and Esketamine—reduce symptoms. The goal is to learn which approach works better in real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Neuronetics
RECRUITINGMalvern, Pennsylvania, 19355, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- A simple pressure test before surgery might reveal your risk of chronic pain
- Can continued therapy keep OCD symptoms at bay?
- Can MRI reveal the Brain's response to deep brain stimulation?